Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ:GILD)

139.37 +3.03 (+2.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,259,957
Open 137.18
Bid (Size) 138.80 (300)
Ask (Size) 140.00 (100)
Prev. Close 136.34
Today's Range 137.17 - 140.35
52wk Range 93.37 - 157.29
Shares Outstanding 1,253,809,440
Dividend Yield 2.27%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Options Action: Naked Put Trade Ideas for March 31
With market volatility on the rise, put premiums are highly elevated, so it’s a good time to check in on Barchart’s Naked Put Screener. 
Via Barchart.com
News headline image
Tango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day Surge ↗
This clinical-stage biotech focused on targeted cancer therapies reported a notable insider sale. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+14.6%
+14.6%
1 Month
-7.1%
-7.1%
3 Month
+11.6%
+11.6%
6 Month
+23.8%
+23.8%
1 Year
+24.4%
+24.4%

More News

Read More
News headline image
$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today ↗
Via Benzinga
News headline image
Gilead Powers Up Its Inflammation Pipeline With Over $1.5 Billion Acquisition ↗
Via Benzinga
GILEAD SCIENCES INC (NASDAQ:GILD): A Durable Dividend Stock for Income Investors ↗
Via Chartmill
News headline image
Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases
From Gilead Sciences, Inc.
Via Business Wire
News headline image
The Record-Breaking M&A Renaissance of 2026: Why Deal Values are Soaring as Volume Dips
Via MarketMinute
Topics Artificial Intelligence Economy Workforce
News headline image
3 Reasons to Avoid GILD and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
News headline image
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal ↗
Via The Motley Fool
Topics Regulatory Compliance
Movers and shakers in today's after-hours session for S&P500 stocks? ↗
Via Chartmill
News headline image
2 Mega-Cap Nasdaq Stocks with Unusual Options Activity: What to Watch
Via Barchart.com
News headline image
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years ↗
Via Benzinga
News headline image
2 Recession-Resistant Dividend Stocks to Buy Now ↗
Via The Motley Fool
Topics Economy
News headline image
What 16 Analyst Ratings Have To Say About Gilead Sciences ↗
Via Benzinga
News headline image
3 Blue-Chip Stocks Built for a Rotating Market ↗
Via MarketBeat
News headline image
These 3 Cash Flow Machines Provide Stability in Uncertain Markets ↗
Via MarketBeat
News headline image
Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Compugen (CGEN) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia
From Gilead Sciences, Inc.
Via Business Wire
News headline image
Arcellx President Sells $10 Million Worth of Shares After Acquisition Announcement ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Arcellx President Sells $10M Worth of Shares After Acquisition Announcement ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
P/E Ratio Insights for Gilead Sciences ↗
Via Benzinga
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
Gilead Sciences Stock: Is GILD Outperforming the Healthcare Sector?
Via Barchart.com
Topics ETFs

Frequently Asked Questions

Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 139.37
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 03/31/26 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 174.74B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 175B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.